India’s Manufacturing Ascent: How Tech and Policy Are Building a New Global Power

India’s Manufacturing Ascent: How Tech and Policy Are Building a New Global Power
India’s ambition to become a $30-35 trillion economy by 2047 is increasingly anchored in a fundamental transformation of its manufacturing sector. Beyond traditional assembly, the nation is strategically weaving together policy incentives, cutting-edge technology, and global supply chain realignment to build a competitive, high-value industrial base. This is not a fleeting trend but a structural shift—a concerted effort to evolve from being the “world’s pharmacy” to a global innovation leader and from a device assembler to a semiconductor manufacturer.
The following table highlights the transformative progress across key, tech-intensive sectors driving this ambition.
| Sector | Key Achievements & Capacity | Global Position & Impact | Primary Growth Driver |
| Electronics & Components | Mobile phone production: ₹5.45 lakh crore in FY25 (28x since 2014-15). 17 new high-value component projects approved (₹71,720 crore). | Major exporter of smartphones and telecom gear; targeting a $500 billion industry by 2030-31. | PLI Schemes, Electronics Components Manufacturing Scheme (ECMS). |
| Semiconductors | 10 approved projects with ~₹1.60 lakh crore investment across 6 states. First indigenous edge chip (ARKA-GKT1) launched. | Building end-to-end ecosystem from fabs to ATMP/OSAT units; attracting anchor firms like Micron. | India Semiconductor Mission (₹76,000 crore outlay), strategic global partnerships. |
| Pharmaceuticals | Exports: $30.47 billion in FY25 (9.4% growth). Over 50% of production exported to 200+ markets. | 3rd largest producer by volume; supplies 60% of global vaccines and 20% of generic drugs. | Scale in generics, rise of CRDMOs/CDMOs, and expansion of Global Capability Centers (GCCs). |
| Solar Manufacturing | 121.68 GW of module manufacturing capacity (operational). 171 GW cell & 279 GW module capacity under construction/planned until 2030. | 2nd largest solar module capacity globally; Gujarat accounts for 42% of operational capacity. | PLI for High-Efficiency Solar PV Modules, strong domestic installation targets. |
The Engine of Growth: Policy, Infrastructure, and Supply Chain Integration
The foundation of India’s manufacturing surge is a multi-layered strategy focused on creating a conducive ecosystem for long-term investment and global integration.
- Strategic Policy Catalysts: The Production Linked Incentive (PLI) scheme is the cornerstone of this push. As of September 2025, it has attracted ₹2 lakh crore in actual investment, generated over ₹18.7 lakh crore in incremental production, and created 12.6 lakh jobs across 14 sectors. Its success lies in linking incentives to output and scale, attracting long-term capital into sectors with sustained global relevance.
- Building Physical and Digital Infrastructure: The National Logistics Policy and PM Gati Shakti initiative aim to reduce crippling logistics costs by enhancing multimodal connectivity. Digitally, platforms like the Bharat Trade Net (BTN) are streamlining export documentation and finance access, especially for MSMEs. This digital public infrastructure is crucial for integrating Indian manufacturers smoothly into global trade flows.
- Deepening the Supply Chain: India is moving beyond final assembly to capture more value upstream. The Electronics Components Manufacturing Scheme (ECMS) exemplifies this, targeting high-value sub-assemblies like camera modules, PCBs, and optical transceivers. This focus on the “mid-stack” is essential for true self-reliance and value addition.
Sectoral Deep Dive: From Scale to Science and Innovation
- Pharmaceuticals: The Quest for High-Value Leadership
India’s pharma sector showcases the journey from volume to value. While it dominates generic drug production, the future lies in innovation. The rise of Contract Research and Development Manufacturing Organizations (CRDMOs) is pivotal. These entities allow India to participate in cutting-edge drug discovery and advanced therapy manufacturing, shifting from a low-cost partner to an integrated innovation hub.
Simultaneously, over 1,800 **Global Capability Centers (GCCs)**—with about 50% of top global life sciences firms having one in India—are evolving from back-office support to strategic R&D centers driving enterprise-wide innovation. This convergence of CRDMOs and GCCs is creating a high-value knowledge ecosystem essential for the sector’s future.
- Semiconductors: A Calculated Ascent in a Complex Arena
India’s semiconductor mission adopts a realistic, stage-wise approach. Instead of immediately challenging cutting-edge logic chip fabrication, it is building a comprehensive ecosystem:
- Assembly, Testing, Marking, and Packaging (ATMP): Led by Micron’s investment in Gujarat, this provides a quicker entry point and job creation.
- Specialized Fabs and Chips: Focus is on mature nodes and specialized chips for automotives, defense, and telecommunications, catering to a serviceable market need.
- Design Innovation: The launch of the indigenous ARKA-GKT1 edge chip and initiatives to skill 85,000 designers highlight a growing focus on owning intellectual property.
This strategy, as noted by the Carnegie Endowment, is yielding “green shoots” by leveraging global partnerships and a sequential federal-state incentive model.
- Electronics and Renewables: Building Dominance Through Scale
Success here is already evident. India has become a major smartphone exporter, with Apple aiming to make over a third of its iPhones in the country by 2027. In renewable energy, the country is building solar manufacturing capacity that far exceeds its near-term domestic installation targets, positioning itself as a future global export hub for clean energy hardware.
The Critical Challenges on the Road Ahead
Despite impressive progress, sustaining this ambition requires overcoming significant structural hurdles.
- The Innovation-Execution Gap: A major challenge, particularly in semiconductors and pharma, is transitioning from executing foreign designs to creating indigenous IP. As one analysis notes, while India houses a significant share of the global chip design workforce, it often “follows specifications prescribed by global multinational firms”. Bridging this gap demands dramatically increased R&D spending and a cultural shift toward high-risk innovation.
- Infrastructure and Regulatory Hurdles: While improving, logistics costs, energy reliability, and bureaucratic processes still lag behind competitor nations. For pharma to become an innovation leader, the EY report emphasizes the need for regulatory agility, stronger intellectual property protection, and alignment with global standards to attract early-phase research.
- Intense Global Competition: India is not alone in seeking manufacturing dominance. Nations like Vietnam, Thailand, and Mexico are also aggressively courting supply chain diversification. India’s success hinges on moving beyond cost competitiveness to offer unparalleled quality, innovation, and reliability.
Conclusion: A Sustainable Ascent, But Not a Guaranteed One
India’s tech-driven manufacturing surge is undoubtedly real and structurally supported. Its strategy—combining demand-side PLI incentives with supply-side ecosystem building in semiconductors, components, and clean energy—is creating a unique convergence of scale, technology, and policy.
The true test of sustainability will be its ability to climb the value chain. Can Indian manufacturers move from assembling iPhones to designing their core chips? Can its pharma companies transition from producing generics to discovering original biologics? The building blocks are in place, and the momentum is strong. However, the journey from a proficient industrializer to a global innovation powerhouse remains a steep climb, requiring sustained policy focus, deep technological education, and a bold embrace of risk-taking in research and development. The world is watching to see if India can convert its formidable potential into enduring global industrial leadership.
What aspect of India’s manufacturing transformation do you find most critical for its long-term success? Is it the development of deep-tech semiconductors, the transition to pharmaceutical innovation, or the building of complete green energy supply chains?
You must be logged in to post a comment.